Insider Stock Trading History of Murray Richard /ca/


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Murray Richard /ca/ since year 2005. The trader's CIK number is 1242935. At the time of this reporting, Murray Richard /ca/ is the CEO and President of Jounce Therapeutics, Inc. . (stock ticker symbol JNCE). See this page for all insider trading activities at Jounce Therapeutics, Inc. .

Note that in the past MURRAY RICHARD /CA/ also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Murray Richard /ca/ since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-09-06 JNCE Jounce Therapeutics, Inc. Option Ex 32,000 .48 15,360
2018-03-08 JNCE Jounce Therapeutics, Inc. Sale 16,334 25.10 409,983
2018-03-08 JNCE Jounce Therapeutics, Inc. Option Ex 16,334 .48 7,840
2018-03-05 JNCE Jounce Therapeutics, Inc. Sale 16,334 21.64 353,386
2018-03-05 JNCE Jounce Therapeutics, Inc. Option Ex 16,334 .48 7,840
2008-04-28 PDLI Protein Design Labs Inc/de Option Ex 20,000 7.85 157,000
2006-03-03 PDLI Protein Design Labs Inc/de Option Ex 15,000 10.32 154,740
2006-03-06 PDLI Protein Design Labs Inc/de Sale 12,673 32.00 405,536
2006-03-03 PDLI Protein Design Labs Inc/de Sale 2,327 32.02 74,510

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Murray Richard /ca/ (CEO and President of Jounce Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.